Diving Deep into Addiction Medicine: Highlights from Episodes 21-30
Episode Overview
Short-acting opioid agonist treatment for hospitalized patients with opioid use disorder Contingency management for coronary artery disease and its impact on coronary plaque regression Evaluation of the Eat Sleep Console approach for neonatal opioid withdrawal Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex Effectiveness of high-dose buprenorphine induction in treating opioid use disorder
Varenicline with counseling did outperform tobacco cessation with placebo and higher biochemically validated cessation and lower seven-day point prevalence of electronic cigarette use. So patients had higher levels of anxiety on the Beck's anxiety inventory.
Ever wondered what the latest research in addiction medicine has to say? In this episode of the 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan take you through a whirlwind tour of Episodes 21-30. Whether you're a healthcare professional or just curious about the science behind addiction treatment, this episode is packed with fascinating findings and practical insights.
From exploring the safety and outcomes of short-acting opioid agonist treatment for hospitalized patients with opioid use disorder, to examining how cash-based contingency management can impact coronary plaque regression among cocaine users with HIV, each study is meticulously unpacked. The hosts also delve into neonatal opioid withdrawal treatments, the complex relationship between smoking cessation and mortality across different demographics, and the efficacy of high-dose buprenorphine induction in emergency settings. But that's not all.
The episode also tackles broader societal issues like public stigma around opioid use disorder and racial inequalities in receiving medication-assisted treatments. You'll hear about the persistence of pain interference after substance use disorder remission and the latest on vaping cessation strategies. Drs. Del Tredici and Keenan don't just present the data; they bring it to life with their engaging discussion and critical analysis.
They break down complex studies into digestible pieces, making it easier for you to apply these insights in real-world scenarios. So, if you're looking to stay ahead in the ever-evolving field of addiction medicine, this episode is a must-listen.